Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease

Mark A Hlatky1, Thomas Quertermous, Derek B Boothroyd

  • 1Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA 94305-5405, USA. hlatky@stanford.edu

American Heart Journal
|November 24, 2007
PubMed

Insights

Genetic variations in the HIF1A gene may protect against acute myocardial infarction (MI) in patients with coronary artery disease (CAD). These HIF1A polymorphisms are linked to stable angina, suggesting a role in cardiovascular disease vulnerability.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Cardiology
  • Ischemia Response Pathways

Background:

  • Coronary artery disease (CAD) patient vulnerability to acute myocardial infarction (MI) varies, potentially due to genetic factors.
  • Investigating genetic components in ischemia response pathways may elucidate differential MI susceptibility.

Purpose of the Study:

  • To determine if polymorphisms in genes related to ischemia response influence MI vulnerability in CAD patients.
  • To assess the association between specific gene polymorphisms and the clinical presentation of CAD (acute MI vs. stable angina).

Main Methods:

  • Prospective cohort study of CAD patients presenting with either acute MI or stable exertional angina.
  • Clinical data collection and genotyping of 34 polymorphisms across 6 key genes (ANGPT1, HIF1A, THBS1, VEGFA, VEGFC, VEGFR2).

Main Results:

  • Three polymorphisms in the HIF1A gene were significantly more prevalent in patients with stable angina compared to those with acute MI.
  • These associations remained significant after adjusting for traditional cardiac risk factors and medications.
  • Variant HIF1A alleles demonstrated reduced HIF-mediated transcriptional activity compared to wild-type alleles in cellular assays.

Conclusions:

  • Polymorphisms in the Hypoxia-Inducible Factor 1-Alpha (HIF1A) gene are associated with a presentation of stable exertional angina rather than acute MI in coronary artery disease.
  • This suggests a potential protective genetic role of specific HIF1A variants against acute myocardial infarction in the context of CAD.
Abstract

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Hypoxia01:23

Hypoxia

Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...